Bioptimus Secures $76 Million in Funding to Advance AI Foundation Model for Biology

Bioptimus, a leading AI foundation model company, has successfully raised a significant funding milestone of $76 million. The funding, spearheaded by Cathay Innovation and other prominent investors like Sofinnova Partners, Bpifrance, Andera Partners, Hitachi Ventures, and more, will drive Bioptimus’s mission to develop the world’s first universal AI foundation model for biology.

The company's model, H-Optimus-0, has already demonstrated superior performance in independent benchmarks, showing unmatched capability in predicting gene expression and subtyping ovarian cancer. Bioptimus aims to break down silos in biological research by integrating data across multiple scales and modalities, providing a holistic view of biology.

With the funding, Bioptimus plans to enhance its multi-modal AI platform, establish strategic partnerships, and expand critical datasets. The investment signifies a major step forward in transforming biological research and unlocking the full complexity of biology. 

By combining AI with an integrated view of biology, Bioptimus aims to empower researchers and industries to tackle complex challenges in medicine, biotechnology, and beyond.

Discover more on Bioptimus funding here.